Acorda Says It's Owed $65M More In MS Drug Fight

By Joyce Hanson · January 11, 2023, 8:17 PM EST

Acorda Therapeutics Inc. has told a New York federal court that an arbitral tribunal got it wrong when it awarded the company only $16 million in a royalties dispute with an...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Acorda Therapeutics, Inc. v. Alkermes plc

Case Number

1:23-cv-00223

Court

New York Southern

Nature of Suit

Other Statutes: Arbitration

Date Filed

January 10, 2023